Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether an Amitriptylin induced change in sleep patterns can be conditioned according to learning theory in healthy participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Alternative Dosing Regimens in the Pharmacotherapy of Insomnia

NCT02139098

Insomnia

TERMINATED PHASE3

Sleep Satisfaction and Psychomotor Performance of Adults

NCT01097382

Sleep Disorders

COMPLETED PHASE4

Combined Behavioral/Pharmacological Therapy for Insomnia

NCT00044629

Sleep Initiation and Maintenance Disorders

COMPLETED PHASE2

Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug

NCT04299490

Sleep Disorder Healthy

COMPLETED PHASE2

Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly

NCT00295386

Insomnia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Group Type EXPERIMENTAL

Amitriptyline

Intervention Type DRUG

Placebo

Intervention Type DRUG

Control group

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amitriptyline

Intervention Type DRUG

Placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 18 years to 69 years
* willingness to refrain from alcohol consumption throughout the study
* regular sleeping habits
* fluent in German language
* is not dependent on driving to get to the study center
* provide written informed consent
* ability to understand the explanations and instructions given by the study physician and the investigator

Exclusion Criteria

* Contraindications to study medication intake according to the information sheet for health professionals (Summary of medicinal Product Characteristics, SmPC) assessed by physical examination (including ECG) and medical history

* allergies to amitriptyline hydrochloride or any of its ingredients
* acute intoxication with alcohol, analgetics, hypnotics or any other psychotropic drug
* urinary retention
* delirium
* untreated closed-angle glaucoma
* prostatic hyperplasia
* pyloric stenosis
* paralytic ileus
* suicidal thoughts
* liver/ kidney/ pulmonary insufficiency
* myasthenia gravis
* hypokalemia
* bradycardia
* coronary heart disease, cardiac arrhythmias, long QT syndrome or other clinically relevant cardiac disorders
* increased risk of seizures/ history of seizures
* substance dependence syndrome/ history of substance dependence syndrome
* Allergies to ingredients of placebo or novel-tasting drink (CS)
* currently pregnant (verified by urine pregnancy test) or lactating
* patients suffering from a mental disorder as verified by the International Diagnosis Checklists (IDCL)
* patients suffering from a medical condition (assessed by the study physician)
* Concomitant medication interfering with study medication intake due to potential interactions
* participation in any other clinical trial 3 months prior to visit 1
* employee of the Sponsor or the principal investigator

Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No